Alberto Ascherio MPH ’89, DPH ’92 was honored for work establishing a link between Epstein-Barr virus and multiple sclerosis, Joel Habener for contributions to the development of GLP-1 drugs, and David Liu for the development of the gene editing platforms.
A Harvard patient-scientist and her husband are among the researchers behind a gene-editing technique that could lead to a treatment for a handful of rare, fatal disorders caused by misfolded proteins in the brain.
Scientist and physician Richard P. Lifton, a prominent leader in biomedical research and higher education, will become a fellow of Harvard College on July 1.
The inaugural session of Ethics IRL, a new series organized by the Edmond and Lily Safra Center for Ethics, focused on the ethical dilemmas of social media’s impact on higher education.
Inspired by his experience with malaria as a child in Ghana, Wyss Institute scientist Kwasi Adu-Berchie SM ’18, PhD ’22 is working to make health care more equitable globally.
Voting is now open for Harvard's Board of Overseers and HAA Elected Directors. Alumni can vote online or by paper ballot for up to six candidates for Overseer and up to six candidates for Elected Director. Voting closes on May 20.
A new University-wide pilot initiative will support faculty working in collaboration with leaders in government, nonprofits, and the private sector to develop solutions to pressing societal problems.
As a graduate student, Rob Devlin PhD ’17 helped develop an innovative mini-lens. Now he runs a startup that produces millions of the devices for use in an array of consumer electronics.
In his first essay for Harvard Magazine, President Alan M. Garber writes about enhancing financial aid and extending education beyond Harvard’s campus.
Harvard College students share how financial aid has allowed them to explore opportunities and make an impact in fields ranging from medicine to government to education.
Harvard Gift Planning recently spoke with N.P. "Narv" Narvekar, CEO of Harvard Management Company (HMC), to get his reflections on the state of the Harvard endowment and HMC.
The inaugural Challenging Barriers to Civil Discourse conference, hosted by Harvard’s Edmond and Lily Safra Center for Ethics, featured scholarship on fostering open, honest exchanges across deep divides.
Karina Herrera AB ’13 discovered her passion for water conservation as student at the Harvard John A. Paulson School for Engineering and Applied Sciences. Now she puts that passion into practice as a senior environmental scientist for the California State Water Resources Control Board.
After experiencing isolation and loss, Harvard College senior Nim Ravid ’25 has led an effort to promote respectful dialogue between Israeli, Jewish, Muslim, and Arab students.
A biotechnology startup launched out of a Harvard chemistry lab is developing new antibiotic compounds that show promise in treating drug-resistant infections and diseases.
Three Harvard Medical School research teams received Blavatnik Therapeutics Challenge Awards to pursue novel approaches to medical challenges, offering potential solutions to people affected by Fragile X syndrome, oxygen deprivation, and Parkinson’s disease.
Harvard Medical School researchers paired a genetic insight with gene editing technology to create a life-changing new therapy for sickle cell disease.